Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I Study of TAS-102 in Japanese Patients with Advanced Solid Tumors
jRCT2080221506Phase 1
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of trifluridine + tipiracil in Nonhematologic neoplasms, sponsored by Taiho Pharmaceutical Co., Ltd.
02
Drugs
trifluridine + tipiracil
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080221506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221506.